The size, burden and cost of disorders of the brain in the UK

495118 2013 JOP27910.1177/0269881113495118Journal of PsychopharmacologyFineberg et al. Original Paper The size, burden and cost of disorders of the...
Author: Laura Shelton
5 downloads 1 Views 799KB Size
495118 2013

JOP27910.1177/0269881113495118Journal of PsychopharmacologyFineberg et al.

Original Paper

The size, burden and cost of disorders of the brain in the UK Naomi A Fineberg1,2,3,13, Peter M Haddad4,12,13, Lewis Carpenter5, Brenda Gannon6, Rachel Sharpe7, Allan H Young8,13, Eileen Joyce9, James Rowe10, David Wellsted5, David J Nutt8,13 and Barbara J Sahakian11,13

Journal of Psychopharmacology 27(9) 761­–770 © The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/0269881113495118 jop.sagepub.com

Abstract Aim: The aim of this paper is to increase awareness of the prevalence and cost of psychiatric and neurological disorders (brain disorders) in the UK. Method: UK data for 18 brain disorders were extracted from a systematic review of European epidemiological data and prevalence rates and the costs of each disorder were summarized (2010 values). Results: There were approximately 45 million cases of brain disorders in the UK, with a cost of €134 billion per annum. The most prevalent were headache, anxiety disorders, sleep disorders, mood disorders and somatoform disorders. However, the five most costly disorders (€ million) were: dementia: €22,164; psychotic disorders: €16,717; mood disorders: €19,238; addiction: €11,719; anxiety disorders: €11,687. Apart from psychosis, these five disorders ranked amongst those with the lowest direct medical expenditure per subject (

Suggest Documents